| Literature DB >> 30255074 |
Nader M Sobhy1, Yasmin H Bayoumi1, Sunil K Mor2, Heba I El-Zahar1, Sagar M Goyal2.
Abstract
Foot and mouth disease virus (FMDV) was isolated from sloughed tongue epithelium of Egyptian cattle presenting with mouth lesions and ropy salivation in two Egyptian governorates (El-Fayoum and Dakahlia). The virus was isolated in Madin-Darby bovine kidney (MDBK) cells and identified by reverse transcription-polymerase chain reaction (RT-PCR). The complete genome was obtained by next generation sequencing. The strains isolated from El-Fayoum and Dakahlia were serotype A and O, respectively and both isolates had identity with the previously reported Egyptian strains. This study reports successive outbreaks of FMDV that occurred in Egypt during 2015-2016 and describes the dynamics of two outbreaks in addition to the use of cardiac biomarkers in the diagnosis of FMD-related myocarditis in calves and its clinical relevance. Serum cardiac troponin1 (cTn I) and creatinine kinase myocardial band (CK-MB) were measured. Mean serum cardiac troponin1 (cTn I) showed significant increase (P < 0.001) in FMDV-infected calves. The increase in fatal and recovered cases was (2.794 ± 0.502 ng/mL) and (1.196 ± 0.443 ng/mL), respectively, compared to the healthy control cases (0.014 ± 0.002 ng/mL). Thus, the serum cTn-I successfully diagnosed FMD-associated myocarditis in calves but not prognostic for the fatal cases. The FMDV sequences described in this study should further help in studying FMDV endemicity in Egypt, tracking the source of infection, selection of control strategies and vaccine updates. The study also determines the clinical relevance of cardiac biomarkers in diagnosis of FMDV-related myocarditis in infected calves.Entities:
Keywords: Biomarkers; Cattle; Egypt; FMD; Myocarditis; Sequencing
Year: 2018 PMID: 30255074 PMCID: PMC6148740 DOI: 10.1016/j.ijvsm.2018.02.001
Source DB: PubMed Journal: Int J Vet Sci Med ISSN: 2314-4599
Forward and reverse VP1 primers with expected amplicon size and annealing temperatures.
| Primer name | Primer Sequence | Annealing | Amplicon size (bp) |
|---|---|---|---|
| F A-1C612 | 55 °C | 815 | |
| F O-1C 124 | 52 °C | 1300 | |
| R(A,O) R2B58 (NK61) | |||
| F SAT-2 | 52 °C | 931 | |
| R SAT-2 |
Fig. 1(a) PCR amplified product with 3D primer, showing single band with 881 bp, (b) PCR amplified product for with 1D primers, showing single band with for serotype O and serotype A at 1300 bp and 815 bp, respectively.
Nucleotides and putative amino acid identities of serotype O/Egypt/2014/KP940473 and A/Egypt/2014/KP940474 complete ORF compared with representative serotypes.
| Egypt/serotype O/2014 | Egypt/serotype A/2014 | ||||||
|---|---|---|---|---|---|---|---|
| aa GBA | I% | nt GBA | I% | aa GBA | I% | nt GBA | I% |
| AAT01771/India | 0.973 | AY593828 | 0.920 | AGZ15282/Egypt | 99.9 | KC440881 | 99.9 |
| AAT01766/Turkey | 0.973 | AY593823 | 0.945 | AAT01723/France | 92.2 | AY593780 | 85.2 |
| AJA91640/India | 0.969 | KJ825809 | 0.904 | AAT01710/Argentina | 92.2 | AY593767 | 84.6 |
| ADR66170/Pakistan | 0.967 | GU384683 | 0.907 | AAT01735/Italy | 92.1 | AY593792 | 85.2 |
| ADR51742/Israel | 0.970 | FJ175662 | 0.902 | AAT01714/Colombia | 92.1 | AY593771 | 84.8 |
| AHK60405/Libya | 0.967 | KJ206909 | 0.903 | AAT01719/Germany | 92.0 | AY593776 | 84.7 |
| AAT01780/Oruguay | 0.968 | AY593837 | 0.897 | AAT01736/Philippines | 91.8 | AY593793 | 84.6 |
| AHK60406/Saudi Arabia | 0.967 | KJ206910 | 0.904 | AAT01694/Netherlands | 91.9 | AY593751 | 85.0 |
| AHE63362/Bangladesh | 0.965 | KF985189 | 0.898 | AAT01721/Spain | 91.9 | AY593778 | 84.7 |
| AJA91633/India | 0.966 | KJ825802 | 0.906 | AAT01704/Kenya | 92.2 | AY593761 | 86.0 |
| AAT01762/Argentina | 0.968 | AY593819 | 0.897 | AAT01703/Russia | 91.9 | AY593760 | 84.7 |
| AFE84735/Iran | 0.967 | JF749851 | 0.906 | AEE65045/India | 92.0 | HQ832585 | 84.4 |
| CAG23917/France | 0.967 | AJ633821 | 0.906 | AAT01709/Kenya | 91.8 | AY593766 | 85.5 |
| CAD62372/South Africa | 0.968 | AJ539140 | 0.907 | AAT01731/Brazil | 91.6 | AY593788 | 83.8 |
| AAT01767/South Korea | 0.966 | AY593824 | 0.904 | AFE84727/Egypt | 91.6 | JF749843 | 84.8 |
| AFZ77049/Turkey | 0.966 | JX040494 | 0.901 | AEQ49433/Pakistan | 91.7 | JN006722 | 84.7 |
| CAD62369/Taiwan | 0.966 | AJ539137 | 0.907 | AAT01734/Iran | 91.7 | AY593791 | 84.3 |
| AIT55226/Turkey | 0.967 | KM268895 | 0.900 | ADM16567/India | 91.7 | HM854022 | 84.7 |
| ADV52243/Malaysia | 0.967 | HQ632768 | 0.905 | AHZ45958/Bangladesh | 91.5 | KJ754939 | 84.2 |
| CAC86575/Brazil | 0.966 | AJ320488 | 0.896 | AER28328/Iraq | 91.6 | JN099697 | 85.0 |
| AGS32328/UK | 0.966 | JX947860 | 0.904 | AEE65039/India | 91.6 | HQ832579 | 84.8 |
| AAM33345/China | 0.966 | AF506822 | 0.907 | ||||
| AGZ15284/Egypt | 0.963 | KC440883 | 0.889 | ||||
| AFE84727/A/Egypt | 0.912 | JF749843 | 0.846 | ||||
aa, Amino acid; nt GBA, nucleotide Genbank accession number; I, identity.
Fig. 2Phylogenetic analysis based on nucleotides of serotype KP940474/A/Egypt/2014 complete ORF. The tree constructed using Maximum Likelihood method with GTR+G+I mode and 1000 bootstrap replicates.
Amino acid substitutions in O/Egypt/2014/KP940473 ORF genome in comparison with the latest isolated O serotype from Egypt AGZ15284/Egypt/2013.
| AGZ15284 | KP940473 | P | AGZ15284 | KP940473 | P | AGZ15284 | KP940473 | P |
|---|---|---|---|---|---|---|---|---|
| N | D | 2 | Q | K | 193 | N | A | 1005 |
| D | G | 5564 | S | T | 258,2067 | I | L | 1081 |
| L | V | 11 | S | P | 360 | V | T | 1262 |
| H | Q | 12,919 | S | R | 419 | I | T | 1354 |
| L | I | 14,17,418 | H | R | 560 | L | M | 1379 |
| T | A | 19,55,194,325,792,865,1139,1544,1568,2020 | A | T | 603,678,1522,1553,1595 | R | H | 1505 |
| R | L | 22 | K | G | 658 | N | G | 1523 |
| T | S | 23 | Y | H | 832,925,1518 | S | N | 1545 |
| Q | T | 26 | K | R | 859,1001,1241,1589,1592,1596,1619 | P | S | 1555 |
| F | L | 31 | E | N | 862 | M | A | 1559 |
| R | K | 38,84,833,881,1594,1643,1904 | S | V | 863 | G | S | 1560 |
| R | N | 47 | S | A | 864 | V | A | 1571 |
| D | E | 64 | S | D | 921 | G | E | 1572 |
| D | S | 73 | E | Q | 922 | V | I | 1855 |
| E | D | 88,1573,1823,1930,2126 | L | F | 955 | N | S | 1959 |
| D | N | 157, 241 | A | H | 1002 | S | C | 2111 |
G, Glycine; P, Proline; A, Alanine; V, Valine; L, Leucine; I, Isoleucine; M, Methionine; C, Cysteine; F, Phenylalanine; Y, Tyrosine; W, Tryptophan; H, Histidine; K, Lysine; R, Arginine; Q, Glutamine; N, Asparagine; E, Glutamic Acid; D, Aspartic Acid; S, Serine; T, Threonine.
Fig. 3Phylogenetic analysis based on nucleotides of serotype KP940473/O/Egypt/2014 complete ORF. The tree constructed using Maximum Likelihood method with GTR+G mode and 1000 bootstrap replicates.
Number of recovered and dead calves after FMD serotype A and O outbreak in Egyptian El-Fayoum and Dakahlia governments 2015–2016.
| Recovered | Dead | ||
|---|---|---|---|
| Serotype | 15 | 1 | |
| 26 | 10 | ||
| Serotype | 8 | 6 | |
| 22 | 20 | ||
| Total | 71 | 37 | |
| 108 | |||
Clinical alterations recorded during examination of fatal and recovered cases.
| Clinical findings | Fatal (37) | Recovered (71) |
|---|---|---|
| State of appetite | Inappetence to anorexia (32 of 37) | Inappetence to anorexia (55 of 71) |
Dullness and depression | Light to severe (27 of 37) | Light depression during the febrile period (22 of 71) |
Posture | Either stand or sternal recumbency, sometimes with extended neck (29 of 37) | Prefer recumbency (36 of 71) |
Gait | Incordination (32 of 37) | Painful (55 of 71) |
Skin | Rough coat with loss of the skin elasticity (20 of 37) | Erected hair (30 of 71) |
Lesions | 10 of 37 | 71 of 71 |
Salivation | 4 of 37 | 71 of 71 |
Oral lesions | 10 of 37 | 71 of 71 |
Lameness | 10 of 37 | 71 of 71 |
Pulse rate and rhythm | (47–110/min) and arrhythmic | (60–94/min) and rhythmic |
Resp. rate and rhythm | 22–76 and rhythmic | 17–35 and rhythmic |
Body temperature | 36.5–41.5° C and fluctuated | 39.2–41.7° C |
Tachycardia | 28 of 37 | 0 of 71 |
Bradycardia | 9 of 37 | 0 of 71 |
Cardiac arrhythmias | 37 of 37 | 0 of 71 |
Abnormal sound | 0 of 37 | 0 of 71 |
Percussion (dull sound) | 20 of 37 | 0 of 71 |
Auscultation (Exaggerated) | 30 of 37 | 15 of 71 |
Bronchial sound | 20 of 37 | 0 of 71 |
| Other observed alterations | ||
| Constipation | 14 of 37 | 0 of 71 |
Levels of CTn I and CK-MB in FMD infected dead and recovered calves compared with healthy control calves.
| CTn I (ng/mL) | CK-MB (U/L) | |||||
|---|---|---|---|---|---|---|
| Mean ± SE | Min. | Max. | Mean ± SE | Min. | Max. | |
| Control | 0.014 ± 0.002c | 0.003 | 0.023 | 74.70 ± 2.23b | 65.00 | 86.00 |
| Fatal cases | 2.794 ± 0.502a | 0.8 | 6.35 | 158.40 ± 25.48a | 72.00 | 240.00 |
| Recovered cases | 1.196 ± 0.443b | 0.013 | 4.25 | 125.40 ± 19.60ab | 68.00 | 230.00 |
All data having different letters are differ significantly at P < 0.05
Fig. 4(a) Pulmonary congestion in FMD fatal cases, (b) Marked pulmonary edema with obliteration of alveoli with a homogenous pink fluid (arrows). H&E X100.
Fig. 5(a) Heart in FMD fatal cases (10 month age, clinical course 1 day), (b) Heart of two months old calf (clinical course 12 days), (c) Cut section cannot detect massive degeneration in the myocardium, (d) Heart of three months old calf, showed epicardial hemorrhage, (e–g) Massive lymphocytic infiltrations (arrows) of the cardiac muscles.